314 results on '"Benito Rafael"'
Search Results
2. Prevalence and changing distribution of HTLV-1 and HTLV-2 infections in Spain
- Author
-
Rodríguez Carmen, Marcaida Goitzane, Roc Lourdes, Ramos Jose, García Juan, Torres Alvaro, Rodríguez Manuel, Calderón Enrique, Hernandez Araceli, Eiros Jose M, Parra Patricia, Benito Rafael, Caballero Estrella, Aguilera Antonio, Treviño Ana, Trigo Matilde, Gomez Cesar, Ortíz de Lejarazu Raul, de Mendoza Carmen, and Soriano Vincent
- Subjects
Immunologic diseases. Allergy ,RC581-607 - Published
- 2011
- Full Text
- View/download PDF
3. Seroprevalence of HTLV infection in Spain among immigrant pregnant women
- Author
-
Rodríguez Carmen, Marcaida Goitzane, Cifuentes Carmen, García Juan, Aguilera Antonio, María Eiros Jose, Roc Lourdes, Ramos Jose, Caballero Estrella, Benito Rafael, Treviño Ana, Trigo Matilde, Arroyo Luis, de Mendoza Carmen, and Soriano Vincent
- Subjects
Immunologic diseases. Allergy ,RC581-607 - Published
- 2011
- Full Text
- View/download PDF
4. Human T-lymphotropic virus-1 infection among Latin American pregnant women living in Spain
- Author
-
Encinas, Begoña, Benito, Rafael, Rojo, Silvia, Reina, Gabriel, Montiel, Natalia, Aguilera, Antonio, Eiros, José María, García-Costa, Juan, Ortega, Diego, Arco, Irene, Hernánez-Batancor, Araceli, Soriano, Vicente, and de Mendoza, Carmen
- Published
- 2024
- Full Text
- View/download PDF
5. Fast and versatile platform for pedicle screw insertion planning
- Author
-
Benito, Rafael, Bertelsen, Álvaro, de Ramos, Verónica, Iribar-Zabala, Amaia, Innocenti, Niccoló, Castelli, Nicoló, Lopez-Linares, Karen, and Scorza, Davide
- Published
- 2023
- Full Text
- View/download PDF
6. Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain
- Author
-
Treviño Ana, Aguilera Antonio, Caballero Estrella, Benito Rafael, Parra Patricia, Eiros Jose M, Hernandez Araceli, Calderón Enrique, Rodríguez Manuel, Torres Alvaro, García Juan, Ramos Jose, Roc Lourdes, Marcaida Goitzane, Rodríguez Carmen, Trigo Matilde, Gomez Cesar, de Lejarazu Raul, de Mendoza Carmen, and Soriano Vincent
- Subjects
HTLV ,Spain ,Seroprevalence ,Epidemiology ,HTLV-3 ,HTLV-4 ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Although most HTLV infections in Spain have been found in native intravenous drug users carrying HTLV-2, the large immigration flows from Latin America and Sub-Saharan Africa in recent years may have changed the prevalence and distribution of HTLV-1 and HTLV-2 infections, and hypothetically open the opportunity for introducing HTLV-3 or HTLV-4 in Spain. To assess the current seroprevalence of HTLV infection in Spain a national multicenter, cross-sectional, study was conducted in June 2009. Results A total of 6,460 consecutive outpatients attending 16 hospitals were examined. Overall, 12% were immigrants, and their main origin was Latin America (4.9%), Africa (3.6%) and other European countries (2.8%). Nine individuals were seroreactive for HTLV antibodies (overall prevalence, 0.14%). Evidence of HTLV-1 infection was confirmed by Western blot in 4 subjects (prevalence 0.06%) while HTLV-2 infection was found in 5 (prevalence 0.08%). Infection with HTLV types 1, 2, 3 and 4 was discarded by Western blot and specific PCR assays in another two specimens initially reactive in the enzyme immunoassay. All but one HTLV-1 cases were Latin-Americans while all persons with HTLV-2 infection were native Spaniards. Conclusions The overall prevalence of HTLV infections in Spain remains low, with no evidence of HTLV-3 or HTLV-4 infections so far.
- Published
- 2012
- Full Text
- View/download PDF
7. HTLV-1-associated myelopathy in Spain
- Author
-
de-Mendoza, Carmen, Pérez, Leire, Rando, Ariadna, Reina, Gabriel, Aguilera, Antonio, Benito, Rafael, Eirós, José María, Rodríguez-Avial, Itziar, Ortega, Diego, Pozuelo, María José, Pena, María José, and Soriano, Vicente
- Published
- 2023
- Full Text
- View/download PDF
8. Human papillomavirus (HPV) infection and intraepithelial neoplasia and invasive cancer of the uterine cervix: a case-control study in Zaragoza, Spain
- Author
-
Moros Manuel, Mayordomo Jose I, Burillo Isabel, Bernal Milagros, Benito Rafael, and Gil Joaquina
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Introduction The raw incidence of cancer of the uterine cervix is Spain is 7,8 per 100.000 inhabitants (adjusted incidence is 5.6). The incidence of this tumor is still low, but a steady increase has been seen, probably related to increasing risk factors. Aim To determine the frequency of infection by different types of human papillomavirus (HPV) in Papanicolau smears from women with and without cancer of the uterine cervix in Spain. Patients and methods A case-control study was performed in women with and without cervical cancer from Zaragoza, Spain. Pap smears from 600 cases (540 women with cervical intraepithelial neoplasms (CIN) and 60 with invasive cancer) and 1200 controls (women without those lesions) were tested by polymerase chain reaction (PCR) and typed by oligonucleotide microarray-based detection. Results HPV was detected in 93.3% of all samples with invasive cancer versus 17.5% of controls. OR for invasive cancer was 55 (95% CI 21.5–140,5). Statistically significant associations were also found for different grades of cervical dysplasia. Conclusion The strong association found between HPV infection, specifically types 16 and 18 and cancer of the uterine cervix in Zaragoza, Spain, stresses the importance of ongoing efforts to institute a vaccine program with recently approved HPV vaccines in order to prevent cervical cancer in this population.
- Published
- 2008
- Full Text
- View/download PDF
9. CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rate
- Author
-
Ortego Javier, Alcedo Javier, Sopeña Federico, García-González María, Arenas Juan, Benito Rafael, Ferrández Angel, Sainz Ricardo, and Lanas Angel
- Subjects
Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Abstract Background & aim The role that H. pylori infection plays in the development of and Barrett's esophagus (BE) is uncertain. We tested the hypothesis that infection with cagA+ Helicobacter pylori strains protects against the development of BE. Methods We studied 104 consecutive patients, residents in an area with a high prevalence of H. pylori infection, with BE and 213 sex- and age-matched controls. H. pylori infection and CagA antibody status were determined by western blot serology. Results H. pylori prevalence was higher in patients with BE than in controls (87.5% vs. 74.6%; OR. 2.3; 95% CI: 1.23–4.59). Increasing age was associated with a higher prevalence of H. pylori (p < 0.05). The prevalence of CagA+ H. pylori serology was similar in patients with BE and controls (64.4% vs. 54.5%; NS). Type I H. pylori infection (CagA+ and VacA+) was similar in patients with BE and controls (44.2% vs. 41.3%; NS). Logistic regression analysis identified alcohol (O.R. 7.09; 95% CI 2.23–22.51), and H. pylori infection (OR: 2.41; 95%CI: 1.20–4.84) but not CagA+ serology as independent factors. Conclusion Neither H. pylori infection nor H. pylori infection by CagA+ strains reduce the risk of BE in a population with high prevalence of H. pylori infection.
- Published
- 2006
- Full Text
- View/download PDF
10. Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies
- Author
-
de Mendoza, Carmen, Pérez, Leire, Fernández-Ruiz, Mario, Pena, María José, Ramos, José Manuel, Richart, Alberto, Piron, María, Rando, Ariadna, Miró, Elisenda, Reina, Gabriel, Encinas, Beatriz, Rojo, Silvia, Rodriguez-Iglesias, Antonio Manuel, Benito, Rafael, Aguilera, Antonio, Treviño, Ana, Corral, Octavio, and Soriano, Vicente
- Published
- 2022
- Full Text
- View/download PDF
11. Activity of cefepime, carbapenems and new β-lactam/β-lactamase inhibitor combinations on Enterobacter cloacae complex and Klebsiella aerogenes in Spain (SMART 2016–2022)
- Author
-
Rodríguez-Villodres, Ángel, primary, Lepe-Balsalobre, Esperanza, additional, Ortiz De La Rosa, José Manuel, additional, Giner Almaraz, Salvador, additional, González De Herrero, Elisa, additional, Cercenado, Emilia, additional, García-Fernández, Sergio, additional, Benito, Rafael, additional, Ponz Mir, Ricardo, additional, Cantón, Rafael, additional, and Lepe, José Antonio, additional
- Published
- 2024
- Full Text
- View/download PDF
12. Clinical Outcome in Human T-Lymphotropic Virus Type 2 Carriers Following Organ Transplantation
- Author
-
Benito, Rafael, Gil, Joaquina, Sahagún, Juan, and Soriano, Vicente
- Published
- 2021
- Full Text
- View/download PDF
13. HIV co-infection in HTLV-1 carriers in Spain
- Author
-
de Mendoza, Carmen, Caballero, Estrella, Aguilera, Antonio, Benito, Rafael, Maciá, Dolores, García-Costa, Juan, and Soriano, Vicente
- Published
- 2019
- Full Text
- View/download PDF
14. Proof‐of‐concept of a robotic‐driven photogrammetric scanner for intra‐operative knee cartilage repair.
- Author
-
Bertelsen, Álvaro, Iribar‐Zabala, Amaia, Otegi‐Alvaro, Ekiñe, Benito, Rafael, López‐Linares, Karen, and Macía, Iván
- Published
- 2024
- Full Text
- View/download PDF
15. HTLV infection in persons with sexually transmitted diseases in Spain
- Author
-
Ayerdi, Oskar, primary, Benito, Rafael, additional, Ortega, Diego, additional, Aguilera, Antonio, additional, Montiel, Natalia, additional, Pintos, Ilduara, additional, Díaz de Santiago, Alberto, additional, Baza, Begoña, additional, Soriano, Vicente, additional, and de Mendoza, Carmen, additional
- Published
- 2023
- Full Text
- View/download PDF
16. Proof‐of‐concept of a robotic‐driven photogrammetric scanner for intra‐operative knee cartilage repair
- Author
-
Bertelsen, Álvaro, primary, Iribar‐Zabala, Amaia, additional, Otegi‐Alvaro, Ekiñe, additional, Benito, Rafael, additional, López‐Linares, Karen, additional, and Macía, Iván, additional
- Published
- 2023
- Full Text
- View/download PDF
17. HTLV-1 infection among Latin American pregnant women living in Spain
- Author
-
Encinas, Begoña, primary, Benito, Rafael, additional, Rojo, Silvia, additional, Reina, Gabriel, additional, Montiel, Natalia, additional, Aguilera, Antonio, additional, Eiros, José María, additional, García-Costa, Juan, additional, Ortega, Diego, additional, Soriano, Vicente, additional, de-Mendoza, Carmen, additional, Calderón, E., additional, Rodríguez-Iglesias, M., additional, Montiel, N., additional, Trujillo, T., additional, Viciana, Cádiz I., additional, Cabezas, Málaga T., additional, Lozano, Almería A., additional, Fernández-Fuertes, E., additional, Fernández, J.M., additional, García, F., additional, Benito, R., additional, Algarate, S., additional, Ducons, M., additional, Roc, L., additional, Cifuentes, C., additional, Fernández-Baca, V., additional, Fernández-Montero, J.V, additional, Maciá, M.D., additional, Hernández-Betancor, A., additional, Martín, A.M., additional, Pena, M.J., additional, Hernández, M., additional, López-Lirola, A.M., additional, Gómez-Sirvent, J.L., additional, Copado, R., additional, Cano, M.E., additional, Rojo, S., additional, Eirós, J.M., additional, Rodríguez, M., additional, Gómez-Hernando, C., additional, González-Praetorius, A., additional, Rando, A., additional, Force, L., additional, Miró, E., additional, Cebollero, A., additional, Delgado, J.F., additional, Rodríguez, G., additional, Fernández-Pereira, L., additional, Aguilera, A., additional, Pereira, S., additional, García, J., additional, Trigo, M., additional, Diz, J., additional, García-Campello, M., additional, Cortizo, S., additional, Pérez, S., additional, Morano, L., additional, Reina, G., additional, Arazamendi, M., additional, Salicio, Y., additional, Ugalde, E., additional, Nieto, M.C., additional, Liendo, P., additional, Goikoetxea, A.J., additional, Ocete, M.D., additional, Ramos, J.M., additional, Escribano, I., additional, Sauleda, S., additional, Pirón, M., additional, González, R., additional, Richart, A., additional, Barea, L., additional, Jiménez, A., additional, Blanco, L., additional, Navarro, L., additional, Ayerdi, O., additional, Baza, B., additional, Rodriguez, C., additional, del-Romero, J., additional, Galar, A., additional, Aldamiz, T., additional, Valeiro, M., additional, Pérez, L., additional, Rodríguez-Avial, I., additional, Martín-Carbonero, L., additional, Fernández-Ruiz, M., additional, Parra, P., additional, Redondo, N., additional, Ruiz-Merlo, T., additional, Pozuelo, M.J., additional, Barreiro, P., additional, Treviño, A., additional, de-Jesús, F., additional, Corral, O., additional, Soriano, V., additional, Pintos, I., additional, Moreno-Torres, V., additional, Carrizo, P., additional, Huertas, A., additional, Vargas-Núñez, J.A., additional, and de-Mendoza, C., additional
- Published
- 2023
- Full Text
- View/download PDF
18. A DISTRIBUTED ENERGY MANAGEMENT PROPOSAL BASED ON A PEER-TO-PEER MODEL
- Author
-
Guimarães, Rafael, additional, Borges, Toni Alex Reis, additional, Torre, Benito Rafael Santana de la, additional, Saba, Hugo, additional, and Nascimento Filho, Aloísio S., additional
- Published
- 2023
- Full Text
- View/download PDF
19. Hepatitis C virus core antigen for screening organ donors and recipients
- Author
-
Benito, Rafael, Arribas, Jorge, Algarate, Sonia, Cebollada, Rocío, and Gude, M. José
- Published
- 2018
- Full Text
- View/download PDF
20. Hospital admissions in individuals with HTLV-1 infection in Spain
- Author
-
Ramos, José-Manuel, de Mendoza, Carmen, Aguilera, Antonio, Barreiro, Pablo, Benito, Rafael, Eiros, Jose M., and Soriano, Vicente
- Published
- 2020
- Full Text
- View/download PDF
21. MALDI-TOF MS as a tick identification tool in a tertiary hospital in Spain
- Author
-
Beltran, Antonio, primary, Palomar, Ana M., additional, Ercibengoa, Maria, additional, Goñi, Pilar, additional, Benito, Rafael, additional, Lopez, Beatriz, additional, and Oteo, Jose Antonio, additional
- Published
- 2023
- Full Text
- View/download PDF
22. Persistence of Anti-S1 IgG against SARS-CoV-2 Eight Months after the Booster Dose of Vaccine in Non-infected Patients
- Author
-
Algarate, Sonia, primary, Serrano, Laura, additional, Bueno, Jessica, additional, Herrero-Cortina, Beatriz, additional, Alvarado, Elena, additional, González-Barriga, María T., additional, Ducons, María, additional, Montero-Marco, Jesica, additional, Arnal, Sara, additional, Acha, Beatriz, additional, Riesgo, María, additional, Taboada, Ana, additional, Sanz-Burillo, Pilar, additional, Yuste, Cristina, additional, and Benito, Rafael, additional
- Published
- 2023
- Full Text
- View/download PDF
23. Usefulness of Non-Skin Samples in the PCR Diagnosis of Mpox (Monkeypox)
- Author
-
Algarate, Sonia, primary, Bueno, Jessica, additional, Crusells, María J., additional, Ara, Mariano, additional, Alonso, Henar, additional, Alvarado, Elena, additional, Ducons, María, additional, Arnal, Sara, additional, and Benito, Rafael, additional
- Published
- 2023
- Full Text
- View/download PDF
24. HTLV infection in persons with sexually transmitted diseases in Spain
- Author
-
Universidade de Santiago de Compostela. Departamento de Microbioloxía e Parasitoloxía, Ayerdi, Oskar, Benito, Rafael, Ortega, Diego, Aguilera Guirao, Antonio, Montiel, Natalia, Pintos, Ilduara, Díaz de Santiago, Alberto, Baza, Begoña, Soriano, Vicente, Mendoza, Carmen de, Spanish HTLV Network, Universidade de Santiago de Compostela. Departamento de Microbioloxía e Parasitoloxía, Ayerdi, Oskar, Benito, Rafael, Ortega, Diego, Aguilera Guirao, Antonio, Montiel, Natalia, Pintos, Ilduara, Díaz de Santiago, Alberto, Baza, Begoña, Soriano, Vicente, Mendoza, Carmen de, and Spanish HTLV Network
- Abstract
Background: HTLV-1 infection is a neglected disease, despite estimates of 10 million people infected worldwide and producing life-threatening illnesses in 10% of carriers. Sexual transmission is the main route of contagion. However, HTLV-1 is not listed among sexually transmitted infections (STIs). Methods: Serum from all consecutive individuals who had attended six STI clinics across Spain during the last 12 months were tested for HTLV antibodies using a commercial enzyme immunoassay (EIA). Reactive samples were confirmed by immunoblot. Results: A total of 2,524 samples were examined. The majority (1,936; 76.7%) belonged to men, of whom 676 (34.9%) were men who have sex with men (MSM) receiving HIV pre-exposure prophylaxis. Although native Spaniards predominated (1,470; 58.2%), up to 593 (23.5%) came from Latin America and 139 (5.5%) were African. A total of 26 individuals were initially EIA reactive and immunoblot confirmed 5 as HTLV-1 and 7 as HTLV-2. All but one HTLV-1+ case came from Latin America. Three were men and two were women. Among Latin Americans, the HTLV-1 seroprevalence was 0.67%. In contrast, all seven HTLV-2+ were native Spaniards and former injection drug users, and all but one were HIV+. Conclusion: The rate of HTLV infection among individuals with STIs in Spain is 0.5%, which is greater than in the general population. These results support the introduction of universal HTLV screening in persons who attend clinics for STIs.
- Published
- 2023
25. Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain
- Author
-
Requena, Silvia, Caballero, Estrella, Lozano, Ana Belén, Ríos-Villegas, María José, Benito, Rafael, Rojo, Silvia, Cabezas, Teresa, Macià, María Dolores, Nieto, María del Carmen, Soriano, Vicente, and de Mendoza, Carmen
- Published
- 2019
- Full Text
- View/download PDF
26. HTLV-1 infection in solid organ transplant donors and recipients in Spain
- Author
-
de Mendoza, Carmen, Roc, Lourdes, Benito, Rafael, Reina, Gabriel, Ramos, José Manuel, Gómez, Cesar, Aguilera, Antonio, Rodríguez-Iglesias, Manuel, García-Costa, Juan, Fernández-Alonso, Miriam, Soriano, Vicente, and on behalf of the Spanish HTLV Network
- Published
- 2019
- Full Text
- View/download PDF
27. Susceptibility to hepatitis B virus infection in adults living in Spain
- Author
-
Soriano, Vicente, primary, Aguilera, Antonio, additional, Benito, Rafael, additional, González‐Díez, Rocío, additional, Miró, Elisenda, additional, Liendo, Paloma, additional, Rodríguez‐Diaz, Juan Carlos, additional, Cabezas, Teresa, additional, Richart, Alberto, additional, Ramos, José Manuel, additional, Barea, Luisa, additional, Álvarez, Carmen, additional, Treviño, Ana, additional, Gómez‐Gallego, Félix, additional, Corral, Octavio, additional, and de Mendoza, Carmen, additional
- Published
- 2023
- Full Text
- View/download PDF
28. MIGHTY: a comprehensive platform for the development of medical image-guided holographic therapy
- Author
-
Iribar-Zabala, Amaia, primary, Benito, Rafael, additional, Sánchez-Merino, Gaspar, additional, Cortes, Camilo A., additional, Garcia-Fidalgo, M. Angeles, additional, Lopez-Linares, Karen, additional, and Bertelsen, Álvaro, additional
- Published
- 2022
- Full Text
- View/download PDF
29. Determination of the concentration of IgG against the spike receptor-binding domain that predicts the viral neutralizing activity of convalescent plasma and serum against SARS-CoV-2
- Author
-
Gobierno de Aragón, Fundación Banco Santander, Universidad de Zaragoza, Instituto de Salud Carlos III, European Commission, Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España), Fundación Inocente Inocente, Aspanoa, Asociación Carrera de la Mujer Ciudad de Monzón, ARAID Foundation, Santiago, Llipsy [0000-0002-1861-5981], Uranga Murillo, Iratxe [0000-0001-8411-984X], Arias, Maykel [0000-0002-9730-2210], González Ramírez, Andrés Manuel [0000-0002-5838-0857], Macías León, Javier [0000-0001-6815-6720], Moreo, Eduardo [0000-0002-0182-201X], Redrado, Sergio [0000-0002-8404-0012], Taleb, V. [0000-0001-9224-5854], Lira-Navarrete, Erandi [0000-0003-2462-7580], Hurtado-Guerrero, R. [0000-0002-3122-9401], Encabo-Berzosa, M. Mar [0000-0001-5533-804X], Hidalgo, Sandra [0000-0003-1629-9978], Gálvez Buerba, Eva Mª [0000-0001-6928-5516], Ramírez-Labrada, Ariel [0000-0002-3888-7036], Miguel, Diego de [0000-0002-8486-8514], Benito, Rafael [0000-0001-5134-1006], Fernández Casanovas, Antonio [0000-0002-2557-4890], Serrano Barcos, Laura [0000-0002-9291-9801], Yuste, Cristina [0000-0003-3667-523X], Villanueva-Saz, Sergio [0000-0001-6209-4282], Paño, José Ramón [0000-0002-9600-8116], Pardo, Julián [0000-0003-0154-0730], Santiago, Llipsy, Uranga Murillo, Iratxe, Arias, Maykel, González Ramírez, Andrés Manuel, Macías-León, Javier, Moreo, Eduardo, Redrado, Sergio, García García, Ana, Taleb, V., Lira-Navarrete, Erandi, Hurtado-Guerrero, R., Aguiló, Nacho, Encabo-Berzosa, M. Mar, Hidalgo, Sandra, Gálvez Buerba, Eva Mª, Ramírez-Labrada, Ariel, Miguel, Diego de, Benito, Rafael, Miranda, Patricia, Fernández Casanovas, Antonio, Domingo, José María, Serrano Barcos, Laura, Yuste, Cristina, Villanueva-Saz, Sergio, Paño, José Ramón, Pardo, Julián, Gobierno de Aragón, Fundación Banco Santander, Universidad de Zaragoza, Instituto de Salud Carlos III, European Commission, Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España), Fundación Inocente Inocente, Aspanoa, Asociación Carrera de la Mujer Ciudad de Monzón, ARAID Foundation, Santiago, Llipsy [0000-0002-1861-5981], Uranga Murillo, Iratxe [0000-0001-8411-984X], Arias, Maykel [0000-0002-9730-2210], González Ramírez, Andrés Manuel [0000-0002-5838-0857], Macías León, Javier [0000-0001-6815-6720], Moreo, Eduardo [0000-0002-0182-201X], Redrado, Sergio [0000-0002-8404-0012], Taleb, V. [0000-0001-9224-5854], Lira-Navarrete, Erandi [0000-0003-2462-7580], Hurtado-Guerrero, R. [0000-0002-3122-9401], Encabo-Berzosa, M. Mar [0000-0001-5533-804X], Hidalgo, Sandra [0000-0003-1629-9978], Gálvez Buerba, Eva Mª [0000-0001-6928-5516], Ramírez-Labrada, Ariel [0000-0002-3888-7036], Miguel, Diego de [0000-0002-8486-8514], Benito, Rafael [0000-0001-5134-1006], Fernández Casanovas, Antonio [0000-0002-2557-4890], Serrano Barcos, Laura [0000-0002-9291-9801], Yuste, Cristina [0000-0003-3667-523X], Villanueva-Saz, Sergio [0000-0001-6209-4282], Paño, José Ramón [0000-0002-9600-8116], Pardo, Julián [0000-0003-0154-0730], Santiago, Llipsy, Uranga Murillo, Iratxe, Arias, Maykel, González Ramírez, Andrés Manuel, Macías-León, Javier, Moreo, Eduardo, Redrado, Sergio, García García, Ana, Taleb, V., Lira-Navarrete, Erandi, Hurtado-Guerrero, R., Aguiló, Nacho, Encabo-Berzosa, M. Mar, Hidalgo, Sandra, Gálvez Buerba, Eva Mª, Ramírez-Labrada, Ariel, Miguel, Diego de, Benito, Rafael, Miranda, Patricia, Fernández Casanovas, Antonio, Domingo, José María, Serrano Barcos, Laura, Yuste, Cristina, Villanueva-Saz, Sergio, Paño, José Ramón, and Pardo, Julián
- Abstract
Passive immunization with hyperimmune plasma from convalescent patients has been proposed as a potentially useful treatment for COVID-19. Nevertheless, its efficacy in patients with COVID-19 remains uncertain. Thus, the establishment and validation of standardized methods that predict the viral neutralizing (VN) activity of plasma against SARS-CoV-2 is of utmost importance to appraise its therapeutic value. Using an in-house quantitative ELISA test and two independent cohorts with a total of 345 donors, we found that plasma and serum from most convalescent donors contained IgG antibodies specific to the spike receptor-binding domain (RBD) of SARS-CoV-2, with varying concentrations which correlate with previous disease severity and gender. Anti-RBD IgG plasma concentration significantly correlated with the plasma/serum VN activity against SARS-CoV-2 in vitro., Several hundred millions of people have been diagnosed of coronavirus disease 2019 (COVID-19), causing millions of deaths and a high socioeconomic burden. SARS-CoV-2, the causative agent of COVID-19, induces both specific T- and B-cell responses, being antibodies against the virus detected a few days after infection. Passive immunization with hyperimmune plasma from convalescent patients has been proposed as a potentially useful treatment for COVID-19. Using an in-house quantitative ELISA test, we found that plasma from 177 convalescent donors contained IgG antibodies specific to the spike receptor-binding domain (RBD) of SARS-CoV-2, although at very different concentrations which correlated with previous disease severity and gender. Anti-RBD IgG plasma concentrations significantly correlated with the plasma viral neutralizing activity (VN) against SARS-CoV-2 in vitro. Similar results were found using an independent cohort of serum from 168 convalescent health workers. These results validate an in-house RBD IgG ELISA test in a large cohort of COVID-19 convalescent patients and indicate that plasma from all convalescent donors does not contain a high enough amount of anti-SARS-CoV-2-RBD neutralizing IgG to prevent SARS-CoV-2 infection in vitro. The use of quantitative anti-RBD IgG detection systems might help to predict the efficacy of the passive immunization using plasma from patients recovered from SARS-CoV-2.
- Published
- 2021
30. Persistence of Anti-S1 IgG against SARS-CoV-2 Eight Months after the Booster Dose of Vaccine in Naive and Previously Infected Healthcare Workers.
- Author
-
Algarate, Sonia, Serrano, Laura, Bueno, Jessica, Herrero-Cortina, Beatriz, Alvarado, Elena, González-Barriga, María T., Ducons, María, Montero-Marco, Jesica, Arnal, Sara, Acha, Beatriz, Riesgo, María, Taboada, Ana, Sanz-Burillo, Pilar, Yuste, Cristina, and Benito, Rafael
- Subjects
MEDICAL personnel ,BOOSTER vaccines ,IMMUNOGLOBULIN G ,COVID-19 vaccines ,SARS-CoV-2 ,IMMUNOGLOBULINS - Abstract
Our aim was to evaluate the immune response of healthcare workers included in the RIPOVAC study, after receiving a booster dose (third dose), in terms of intensity and persistence of induced antibodies. In the second phase of the RIPOVAC study, between December 2021 and January 2022, eight months after the second dose, 389 voluntary, immunocompetent, non-pregnant healthcare workers received a booster dose of SARS-CoV-2 vaccine, and a serum sample was obtained. Two groups of patients were established: with and without previous SARS-CoV-2 infection. In order to quantify anti-S1 IgG (AU/mL) we used CMIA (Abbott). All of the health workers were anti-S IgG positive 8 months after receiving the booster dose of the vaccine, with a mean of 17,040 AU/mL. In 53 patients without previous infection, antibody levels increased by a mean of 10,762 AU/mL. This figure is seven times higher than the one produced after the second dose (1506 AU/mL). The booster dose produces a robust elevation of the antibody level, which persists at 8 months, with levels significantly higher than those reached after the second dose, which allow one to predict a persistence of more than one year. The study demonstrates the efficacy of the booster dose of anti-SARS-CoV-2 vaccines. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
31. MIGHTY: a comprehensive platform for the development of medical image-guided holographic therapy.
- Author
-
Iribar-Zabala, Amaia, Benito, Rafael, Sánchez-Merino, Gaspar, Cortes, Camilo A., Garcia-Fidalgo, M. Angeles, Lopez-Linares, Karen, and Bertelsen, Álvaro
- Subjects
AUGMENTED reality ,SOFTWARE development tools ,HOLOGRAPHY ,COMPUTER-assisted image analysis (Medicine) ,OPERATING rooms ,MEDICAL robotics - Abstract
With the use of different technological equipment, it becomes a complex challenge to have a fully integrated operating room, with adequate communication between devices. In this paper, we present the Medical Image Guided and Holographic TherapY (MIGHTY) platform, a software development kit for surgical applications that integrates computer-assisted planning, augmented reality, real-time imaging and collaborative robotics in the same environment. To show MIGHTY's capabilities, a representative use case – abdominal biopsy – is addressed. We tested quantitatively the throughput of the involved applications, and the precision of the scene-tracking methods. Throughput results scored satisfactorily high in regards to the system's real-time performance, and the tracking methods, although improvable, were good for the purpose of this work, which aims on the integration and cooperation of all the involved technologies, rather than on the individual accuracy of each one of them. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
32. Assessment of humoral immune response to two mRNA SARS-CoV-2 vaccines (Moderna and Pfizer) in healthcare workers fully vaccinated with and without a history of previous infection
- Author
-
Serrano, Laura, Algarate, Sonia, Herrero-Cortina, Beatriz, Bueno, Jessica, González-Barriga, Maria T., Ducons, Maria, Montero-Marco, Jesica, Acha, Beatriz, Taboada, Ana, Sanz-Burillo, Pilar, Yuste, Cristina, Benito, Rafael, and RIPOVAC, Study Group
- Subjects
COVID-19 Vaccines ,Post-vaccination ,SARS-CoV-2 ,Health Personnel ,Vaccination ,COVID-19 ,General Medicine ,Antibodies, Viral ,Applied Microbiology and Biotechnology ,Immunity, Humoral ,Spain ,Pfizer ,Immunoglobulin G ,Moderna ,Spike Glycoprotein, Coronavirus ,mRNA SARS-CoV- 2 vaccines ,RIPOVAC ,Humans ,Healthcare workers ,Immune response ,Anti-S IgG SARS-CoV- 2 ,BNT162 Vaccine ,Biotechnology ,2019-nCoV Vaccine mRNA-1273 - Abstract
Aims Presence of anti-S1 region of SARS-CoV-2 spike protein was analysed, at two and eight months, in 477 immunocompetent healthcare workers in Zaragoza, Spain, vaccinated with mRNA-1273 (Moderna) or BNT162b2 (Pfizer). Methods and results Antibody analysis was performed with Alinity i System (Abbott). At 2 months, 100% of vaccinated had anti-S1 IgG (mean = 13,285 AU ml−1). This value was significantly higher with Moderna (18,192 AU ml−1) than with Pfizer (10,441 AU ml−1). The mean value of anti-S1 IgG after vaccination was significantly higher in patients with than without previous infection (18,539 vs. 7919 AU ml−1); in both groups was significantly higher with Moderna than with Pfizer (21,881 vs. 15,733 AU ml−1 and 11,949 vs. 6387 AU ml−1), respectively. At 8 months, 100% of patients were IgG positive, with higher levels with Moderna than with Pfizer. Nevertheless, in ensemble of cases, a mean decrease of antibody levels of 11,025 AU ml−1 was observed. Conclusion At 2 and 8 months after vaccination, IgG response persists with both vaccines but with important decrease which suggests the need for revaccination. Significance and impact of study The study contributes to know the immune status after vaccination with two of more used anti-SARS-CoV-2 vaccines. This knowledge is important for establishing the best vaccination strategy
- Published
- 2022
33. Human T-lymphotropic virus type 1 infection and disease in Spain
- Author
-
de Mendoza, Carmen, Caballero, Estrella, Aguilera, Antonio, Requena, Silvia, de Lejarazu, Raúl Ortiz, Pirón, María, González, Rocío, Jiménez, Ana, Roc, Lourdes, Treviño, Ana, Benito, Rafael, Fernández-Alonso, Miriam, Aguinaga, Aitziber, Rodríguez, Carmen, García-Costa, Juan, Blanco, Lidia, Ramos, José M., Calderón, Enrique, Eirós, José M., Sauleda, Silvia, Barreiro, Pablo, and Soriano, Vicente
- Published
- 2017
- Full Text
- View/download PDF
34. The slowdown of new infections by human retroviruses has reached a plateau in Spain.
- Author
-
de Mendoza, Carmen, Carrizo, Paula, Sauleda, Silvia, Richart, Alberto, Rando, Ariadna, Miró, Elisenda, Benito, Rafael, Ayerdi, Oscar, Encinas, Begoña, Aguilera, Antonio, Reina, Gabriel, Rojo, Silvia, González, Rocío, Fernández‐Ruiz, Mario, Liendo, Paloma, Montiel, Natalia, Roc, Lourdes, Treviño, Ana, Pozuelo, María José, and Soriano, Vicente
- Subjects
SEXUALLY transmitted diseases ,RETROVIRUSES ,RETROVIRUS diseases ,HTLV ,PREGNANT women ,PARACOCCIDIOIDOMYCOSIS - Abstract
The 2022 annual meeting of the HTLV & HIV‐2 Spanish Network was held in Madrid on December 14. We summarize here the main information presented and discussed at the workshop and review time trends for human retroviral infections in Spain. As transmissible agents, infections by human retroviruses are of obligatory declaration. Until the end of 2022, the Spanish national registry had recorded 451 cases of HTLV‐1, 821 of HTLV‐2, and 416 of HIV‐2. For HIV‐1, estimates are of 150 000 people currently living with HIV‐1 and 60 000 cumulative deaths due to AIDS. During year 2022, new diagnoses in Spain were of 22 for HTLV‐1, 6 for HTLV‐2, and 7 for HIV‐2. The last updated figures for HIV‐1 are from 2021 and counted 2786 new diagnoses. The slowdown in yearly infections for HIV‐1 in Spain points out that new strategies are needed to achieve the United Nations 95‐95‐95 targets by 2025. For the remaining neglected human retroviral infections, their control might be pushed throughout four interventions: (1) expanding testing; (2) improving education and interventions aimed to reduce risk behaviors; (3) facilitating access to antiretrovirals as treatment and prevention, including further development of long‐acting formulations; and (4) increasing vaccine research efforts. Spain is a 47 million population country in South Europe with strong migration flows from HTLV‐1 endemic regions in Latin America and Sub‐Saharan Africa. At this time universal HTLV screening has been implemented only in the transplantation setting, following the report of 5 cases of HTLV‐associated myelopathy shortly after transplantation of organs from HTLV‐1 positive donors. There are four target populations for expanding testing and unveiling asymptomatic carriers responsible for silent HTLV‐1 transmissions: (1) migrants; (2) individuals with sexually transmitted infections; (3) pregnant women; and (4) blood donors. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
35. El canto colectivo: placentera herramienta para el enriquecimiento musical del coralista
- Author
-
Benito, Rafael Carlos, primary, Cañizares Sevilla, Ana Belén, additional, and González López, Ignacio, additional
- Published
- 2022
- Full Text
- View/download PDF
36. Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies : on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network
- Author
-
de Mendoza, Carmen, Pérez, Leire, Fernández-Ruiz, Mario, Pena, María José, Ramos, José Manuel, Richart, Alberto, Piron, María, Rando, Ariadna, Miró, Elisenda, Reina, Gabriel, Encinas, Beatriz, Rojo, Silvia, Rodríguez-Iglesias, Antonio Manuel, Benito, Rafael, Aguilera Guirao, Antonio, Treviño, Ana, Corral, Octavio, and Soriano, Vicente
- Subjects
Late presentation ,HTLV-1 ,Myelopathy ,Diagnosis ,Sexually transmitted infections - Abstract
Altres ajuts: Fundación Mutua Madrileña (AP-174112020). Objectives: Although only 10% of persons infected with human T-lymphotropic virus type 1 (HTLV-1) may develop virus-associated illnesses over their lifetime, missing the earlier diagnosis of asymptomatic carriers frequently leads to late presentation. Methods: A nationwide HTLV-1 register was created in Spain in 1989. We examined the main demographics and clinical features at the time of the first diagnosis for more than three decades. Results: A total of 428 individuals infected with HTLV-1 had been reported in Spain until the end of 2021. Up to 96 (22%) individuals presented clinically with HTLV-1-associated conditions, including subacute myelopathy (57%), T-cell lymphoma (34%), or Strongyloides stercoralis infestation (8%). Since 2008, HTLV-1 diagnosis has been made at blood banks (44%) or clinics (56%). Native Spaniards and Sub-Saharan Africans are overrepresented among patients presenting with HTLV-1-associated illnesses suggesting that poor epidemiological and/or clinical suspicion, which led to the late presentation are more frequent in them than carriers from Latin America (LATAM) (31.7% vs 20.4%, respectively; P = 0.015). Conclusion: HTLV-1 infection in Spain is frequently diagnosed in patients presenting with characteristic illnesses. Although screening in blood banks mostly identifies asymptomatic carriers from LATAM, a disproportionately high number of Spaniards and Africans are diagnosed too late at the time of clinical manifestations. Expanding testing to all pregnant women and clinics for sexually transmitted infections could help to unveil HTLV-1 asymptomatic carriers.
- Published
- 2022
37. Análisis de un modelo de gestión comunitaria-empresarial, para la administración de una pequeña central hidroeléctrica y el servicio de electricidad en la localidad Suro Antivo, Tumbadén, San Pablo, Cajamarca
- Author
-
Ramírez Ocas, Benito Rafael and Alzamora de Los Godos Urcia, Luis Alex
- Subjects
purl.org/pe-repo/ocde/ford#5.09.00 [https] ,Centrales hidroeléctricas--Administración ,Participación social--Perú ,Administración de proyectos ,Distrito) [Electrificación rural--Perú--Tumbadén (Cajamarca] ,Comunidad--Organización - Abstract
En el 2011 la Organización No Gubernamental (ONG) Practical Action instaló una pequeña central hidroeléctrica (PCH) en el caserío Suro Antivo, distrito Tumbadén, provincia San Pablo, Cajamarca; e implementó un modelo de gestión comunitaria que incluye un componente empresarial y un conjunto de elementos que hacen posible su funcionamiento. La presente investigación busca aportar a la comprensión de los factores que hacen posible su permanencia en el tiempo, para lo cual se analizan: i) las características del proceso administrativo en el entorno comunitario; ii) las particularidades respecto de la organización de la población y el involucramiento de los actores; iii) los beneficios y limitaciones del modelo de gestión. El objetivo general de la investigación es: Identificar las características, beneficios y limitaciones del modelo de gestión del proyecto pequeña central hidroeléctrica Suro Antivo, distrito Tumbadén en la provincia San Pablo, Cajamarca; analizando los elementos que influyen en su funcionamiento, para proponer mejoras que contribuyan a fortalecerlo, como parte de las estrategias para lograr el acceso sostenible de la electricidad en el sector rural; y se han planteado tres objetivos específicos: 1) Evaluar las acciones de planeación, organización, dirección y control en torno al modelo de gestión del servicio de electricidad; 2) Analizar las características de organización y participación de la población en torno al modelo de gestión del servicio de electricidad en Suro Antivo; 3) Identificar los beneficios y limitaciones del modelo de gestión de la PCH. Dicho análisis se orienta desde tres enfoques: El Enfoque de Capacidades; Enfoque de Desarrollo Territorial; y el Enfoque de Derechos. Lograr el acceso universal a la energía, en este caso específico la electricidad, y que esta sea asequible, fiable y moderna, como se plantea en el Objetivo de Desarrollo Sostenible (ODS) 7, requiere replantear y/o flexibilizar la forma de intervención en los proyectos y programas, haciendo partícipes a las comunidades en el proceso; involucrando a la población desde la identificación de las alternativas de solución; considerando el potencial energético del territorio y con ello el tipo de tecnología a utilizar; ampliando sus conocimientos en aspectos técnicos y administrativos; fortaleciendo sus capacidades con base en los atributos socio culturales que las caracteriza; y una definición más amplia que aquella que las reduce a clientes o receptoras del servicio de electricidad.
- Published
- 2022
38. New pattern of EGFR amplification in glioblastoma and the relationship of gene copy number with gene expression profile
- Author
-
Lopez-Gines, Concha, Gil-Benso, Rosario, Ferrer-Luna, Ruben, Benito, Rafael, Serna, Eva, Gonzalez-Darder, Jose, Quilis, Vicente, Monleon, Daniel, Celda, Bernardo, and Cerdá-Nicolas, Miguel
- Published
- 2010
- Full Text
- View/download PDF
39. Comparação de metodos de resolução de fluxo otimo em redes
- Author
-
Velez Benito, Rafael Carlos, Perin Filho, Clovis, 1947, Universidade Estadual de Campinas. Instituto de Matemática, Estatística e Ciência da Computação, Programa de Pós-Graduação em Matemática Aplicada, and UNIVERSIDADE ESTADUAL DE CAMPINAS
- Subjects
Redes de computadores ,Redes de informação - Abstract
Orientador: Clovis Perin Filho Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Matematica, Estatistica e Ciencia da Computação Resumo: Não informado Abstract: Not informed Mestrado Mestre em Matemática Aplicada
- Published
- 2021
- Full Text
- View/download PDF
40. Association of PSCA rs2294008 gene variants with poor prognosis and increased susceptibility to gastric cancer and decreased risk of duodenal ulcer disease
- Author
-
García-González, María Asunción, Bujanda, Luis, Quintero, Enrique, Santolaria, Santos, Benito, Rafael, Strunk, Mark, Sopeña, Federico, Thomson, Concha, Pérez-Aisa, Angeles, Nicolás-Pérez, David, Hijona, Elizabeth, Carrera-Lasfuentes, Patricia, Piazuelo, Elena, Jiménez, Pilar, Espinel, Jesús, Campo, Rafael, Manzano, Marisa, Geijo, Fernando, Pellise, María, Zaballa, Manuel, González-Huix, Ferrán, Espinós, Jorge, Titó, Llúcia, Barranco, Luis, Pazo-Cid, Roberto, and Lanas, Angel
- Published
- 2015
- Full Text
- View/download PDF
41. Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1
- Author
-
Treviño, Ana, Vicario, Jose L., Lopez, Mariola, Parra, Patricia, Benito, Rafael, Ortiz de Lejarazu, Raul, Ramos, Jose M., del Romero, Jorge, de Mendoza, Carmen, and Soriano, Vincent
- Published
- 2013
- Full Text
- View/download PDF
42. Genotype Distribution Change After Human Papillomavirus Vaccination in Two Autonomous Communities in Spain
- Author
-
Freire-Salinas, Javier, primary, Benito, Rafael, additional, Azueta, Ainara, additional, Gil, Joaquina, additional, Mendoza, Claudia, additional, Nicolás, Montserrat, additional, García-Berbel, Pilar, additional, Algarate, Sonia, additional, and Gómez-Román, Javier, additional
- Published
- 2021
- Full Text
- View/download PDF
43. High viral SARS-CoV-2 load in placenta of patients with hypertensive disorders after COVID-19 during pregnancy
- Author
-
FABRE, MARTA, primary, CALVO, PILAR, additional, RUIZ-MARTINEZ, SARA, additional, PERAN, MARIA, additional, OROS, DANIEL, additional, MEDEL, ANA, additional, STRUNK, MARK, additional, BENITO, RAFAEL, additional, SCHOORLEMMER, JON, additional, and PAULES, CRISTINA, additional
- Published
- 2021
- Full Text
- View/download PDF
44. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant
- Author
-
López, Mariana G., Chiner-Oms, Álvaro, García de Viedma, Darío, Ruiz-Rodriguez, Paula, Bracho, Maria Alma, Cancino-Muñoz, Irving, D’Auria, Giuseppe, de Marco, Griselda, García-González, Neris, Goig, Galo Adrian, Gómez-Navarro, Inmaculada, Jiménez-Serrano, Santiago, Martinez-Priego, Llúcia, Ruiz-Hueso, Paula, Ruiz-Roldán, Lidia, Torres-Puente, Manuela, Alberola, Juan, Albert, Eliseo, Aranzamendi Zaldumbide, Maitane, Bea-Escudero, María Pilar, Boga, Jose Antonio, Bordoy, Antoni E., Canut-Blasco, Andrés, Carvajal, Ana, Cilla Eguiluz, Gustavo, Cordón Rodríguez, Maria Luz, Costa-Alcalde, José J., de Toro, María, de Toro Peinado, Inmaculada, del Pozo, Jose Luis, Duchêne, Sebastián, Fernández-Pinero, Jovita, Fuster Escrivá, Begoña, Gimeno Cardona, Concepción, González Galán, Verónica, Gonzalo Jiménez, Nieves, Hernáez Crespo, Silvia, Herranz, Marta, Lepe, José Antonio, López-Causapé, Carla, López-Hontangas, José Luis, Martín, Vicente, Martró, Elisa, Milagro Beamonte, Ana, Montes Ros, Milagrosa, Moreno-Muñoz, Rosario, Navarro, David, Navarro-Marí, José María, Not, Anna, Oliver, Antonio, Palop-Borrás, Begoña, Parra Grande, Mónica, Pedrosa-Corral, Irene, Pérez González, Maria Carmen, Pérez-Lago, Laura, Pérez-Ruiz, Mercedes, Piñeiro Vázquez, Luis, Rabella, Nuria, Rezusta, Antonio, Robles Fonseca, Lorena, Rodríguez-Villodres, Ángel, Sanbonmatsu-Gámez, Sara, Sicilia, Jon, Soriano, Alex, Tirado Balaguer, María Dolores, Torres, Ignacio, Tristancho, Alexander, Marimón, José María, Pérez-Tur, Jordi, Catalán-Alonso, Pilar, Suárez González, Julia, Muñoz, Patricia, Ruiz-Rodríguez, Paula, Bracho, María Alma, Martínez Priego, Llúcia, Galán-Vendrell, Inmaculada, De Marco, Griselda, Ferrús-Abad, María Loreto, Carbó-Ramírez, Sandra, Nogueira, Jose Miguel, Camarena, Juan José, Martínez Expósito, Óscar, Antona Urieta, Nerea, Castelló-Abietar, Cristian, Rojo-Alba, Susana, Álvarez-Argüelles, Marta Elena, Melón, Santiago, Antuori, Adrián, Fernández-Navarro, Anabel, Lecaroz Agara, Maria Concepción, Gómez-González, Carmen, Aguirre-Quiñonero, Amaia, López-Mirones, José Israel, Fernández-Torres, Marina, Almela-Ferrer, Maria Rosario, Fregeneda-Grandes, Juan Miguel, Argüello, Héctor, Sorarrain, Ane, Trastoy, Rocío, Barbeito Castiñeiras, Gema, Coira, Amparo, Pérez del Molino, María Luisa, Aguilera, Antonio, Mediavilla Gradolph, Maria Concepción, Fernández-Alonso, Mirian, González-Recio, Oscar, Gutiérrez-Rivas, Mónica, Jiménez Clavero, Miguel Ángel, Ocete Mochón, María Dolores, Medina-Gonzalez, Rafael, Reina, Jordi, Gómez-Ruiz, Maria Dolores, Gonzalez-Barbera, Eva M., Molina, Antonio J., Fernandez-Villa, Tania, Martínez-Cameo, Nieves Felisa, Gracia-Grataloup, Yolanda, Tirado Balaguer, Maria Dolores, Gómez Alonso, Bárbara, Arjona Zaragozí, Francisco José, Chamizo López, Francisco Javier, Bordes-Benítez, Ana, Rabella, Núria, Navarro, Ferran, Miró, Elisenda, Simarro Córdoba, Encarnación, Lozano-Serra, Julia, Soriano, Álex, Roig Sena, Francisco Javier, Vanaclocha Luna, Hermelinda, Sanmartín, Isabel, García-Souto, Daniel, Pequeño-Valtierra, Ana, Tubio, Jose M. C., Temes, Javier, Rodríguez-Castro, Jorge, Santamarina García, Martín, Rodríguez-Iglesias, Manuel, Galán-Sanchez, Fátima, Rodríguez-Pallares, Salud, Azcona-Gutiérrez, José Manuel, Blasco-Alberdi, Miriam, Mayor, Alfredo, García-Basteiro, Alberto L., Moncunill, Gemma, Dobaño, Carlota, Cisteró, Pau, Mitjà, Oriol, González-Beiras, Camila, Vall-Mayans, Martí, Corbacho-Monné, Marc, Alemany, Andrea, Muñoz-Cuevas, Cristina, Rodríguez-Rodríguez, Guadalupe, Benito, Rafael, Algarate, Sonia, Bueno, Jessica, Vergara-Gómez, Andrea, Martínez, Miguel J., Vila, Jordi, Rubio, Elisa, Peiró-Mestres, Aida, Navero-Castillejos, Jessica, Posada, David, Valverde, Diana, Estévez, Nuria, Fernández-Silva, Iria, de Chiara, Loretta, Gallego-García, Pilar, Varela, Nair, Gómez-Pinedo, Ulises, Gozalo-Margüello, Mónica, Cano García, Maria Eliecer, Méndez-Legaza, José Manuel, Rodríguez-Lozano, Jesus, Siller, María, Pablo-Marcos, Daniel, Ruiz-García, Maria Montserrat, Galiana, Antonio, Sánchez-Almendro, Judith, Gascón Ros, Maria Isabel, Torregrosa-Hetland, Cristina Juana, Pastor Boix, Eva María, Cascales Ramos, Paloma, Garcinuño Enríquez, Pedro Luis, Raga Borja, Salvador, González Cantó, Julia, Martínez Macias, Olalla, de Salazar, Adolfo, Viñuela González, Laura, Chueca, Natalia, García, Federico, Gómez-Camarasa, Cristina, Farga Martí, Amparo, Falcón, Rocío, Domínguez-Márquez, Victoria, Planas, Anna M., Fernández-Cádenas, Israel, Marcos, Maria Ángeles, Ezpeleta, Carmen, Navascués, Ana, Miqueleiz Zapatero, Ana, Segovia, Manuel, Moreno-Docón, Antonio, Viedma, Esther, Recio Martínez, Raúl, Muñoz-Gallego, Irene, Gonzalez-Bodi, Sara, Folgueira, Maria Dolores, Mingorance, Jesús, Dahdouh, Elias, Lázaro-Perona, Fernando, Rodríguez-Tejedor, María, Romero-Gómez, María Pilar, García-Rodríguez, Julio, Galán, Juan Carlos, Rodríguez-Dominguez, Mario, Martínez-García, Laura, Abreu Di Berardino, Melanie, Ponce-Alonso, Manuel, González-Alba, Jose Maria, Sanz-Muñoz, Ivan, Pérez San José, Diana, Gil Fortuño, Maria, Bellido-Blasco, Juan B., Yagüe Muñoz, Alberto, Hernández Pérez, Noelia, Buj Jordá, Helena, Pérez Olaso, Óscar, González Praetorius, Alejandro, Martínez Ramírez, Nora Mariela, Ramírez Marinero, Aida, Padilla León, Eduardo, Vilas Basil, Alba, Canal Aranda, Mireia, Bernet Sánchez, Albert, Bellés Bellés, Alba, López González, Eric, Prats Sánchez, Iván, García-González, Mercè, Martínez-Lirola, Miguel José, Rodríguez Maresca, Manuel Ángel, Cabezas Fernández, Maria Teresa, Carrillo Gil, María Eugenia, Ventero Martín, Maria Paz, Molina Pardines, Carmen, Orta Mira, Nieves, Navarro Cots, María, Vidal Catalá, Inmaculada, García Nava, Isabel, Illescas Fernández-Bermejo, Soledad, Martínez-Alarcón, José, Torres-Narbona, Marta, Colmenarejo, Cristina, García-Agudo, Lidia, Pérez García, Jorge A., Yago López, Martín, Goberna Bravo, María Ángeles, Simón García, Victoria, Llop Furquet, Gonzalo, Iranzo Tatay, Agustín, Moreno-Marro, Sandra, Lozano Rodríguez, Noelia, Broseta Tamarit, Amparo, Badiola Díez, Juan José, Martínez-Ramírez, Amparo, Dopazo, Ana, Callejas, Sergio, Benguría, Alberto, Aguado, Begoña, Alcamí, Antonio, Bermejo Bermejo, Marta, Ramos-Ruíz, Ricardo, Fernández Soria, Víctor Manuel, Simón Soria, Fernando, Roig Cardells, Mercedes, Coscolla, Mireia, González-Candelas, Fernando, Comas, Iñaki, Instituto de Salud Carlos III, Consejo Superior de Investigaciones Científicas (España), Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España), European Research Council, European Commission, Generalitat Valenciana, Chiner-Oms, Álvaro [0000-0002-0463-0101], Ruiz-Rodríguez, Paula [0000-0003-0727-5974], D'Auria, Giuseppe [0000-0003-0672-2541], Gómez-Navarro, Inmaculada [0000-0002-5235-7365], Jiménez Serrano, Santiago [0000-0003-2917-6053], Aranzamendi Zaldumbide, Maitane [0000-0003-2432-7078], Boga, José Antonio [0000-0002-5500-9972], Bordoy, Antoni E. [0000-0002-1165-542X], Costa-Alcalde, José J. [0000-0002-1916-2216], Toro Peinado, Inmaculada de [0000-0002-8151-3275], López-Causapé, Carla [0000-0003-2228-2005], Martín, Vicente [0000-0003-0552-2804], Moreno-Muñoz, Rosario [0000-0002-0185-5612], Parra Grande, Mónica [0000-0002-8330-7467], Balaguer, María Dolores [0000-0003-3808-7300], Coscolla, Mireia [0000-0003-0752-0538], González-Candelas, Fernando [0000-0002-0879-5798], Comas, Iñaki [0000-0001-5504-9408], Ministerio de Ciencia (España), Generalitat Valenciana (España), Chiner-Oms, Álvaro, Ruiz-Rodríguez, Paula, D'Auria, Giuseppe, Gómez-Navarro, Inmaculada, Jiménez Serrano, Santiago, Aranzamendi Zaldumbide, Maitane, Boga, José Antonio, Bordoy, Antoni E., Costa-Alcalde, José J., Toro Peinado, Inmaculada de, López-Causapé, Carla, Martín, Vicente, Moreno-Muñoz, Rosario, Parra Grande, Mónica, Balaguer, María Dolores, Coscolla, Mireia, González-Candelas, Fernando, Comas, Iñaki, and Marimon, Jose Maria
- Subjects
DYNAMICS ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Physical Distancing ,Biology ,Severity of Illness Index ,Article ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,law ,Pandemic ,Quarantine ,Genetics ,Humans ,Clade ,Phylogeny ,030304 developmental biology ,0303 health sciences ,Models, Statistical ,SARS-CoV-2 ,Incidence (epidemiology) ,Incidence ,Genetic variants ,COVID-19 ,Genomics ,New variant ,Dynamics ,Virus ,3. Good health ,Spain ,Communicable Disease Control ,VIRUS ,030217 neurology & neurosurgery ,Demography - Abstract
SeqCOVID-Spain consortium: Álvaro Chiner-Oms, Irving Cancino-Muñoz, Mariana G. López, Manuela Torres-Puente, Inmaculada Gómez-Navarro, Santiago Jiménez-Serrano, Jordi Pérez-Tur, Darío García de Viedma, Laura Pérez-Lago, Marta Herranz, Jon Sicilia, Pilar Catalán-Alonso, Julia Suárez González, Patricia Muñoz, Mireia Coscolla, Paula Ruiz-Rodríguez, Fernando González-Candelas, Iñaki Comas, Lidia Ruiz-Roldán, María Alma Bracho, Neris García-González, Llúcia Martínez Priego, Inmaculada Galán-Vendrell, Paula Ruiz-Hueso, Griselda De Marco, María Loreto Ferrús-Abad, Sandra Carbó-Ramírez, Giuseppe D’Auria, Galo Adrian Goig, Juan Alberola, Jose Miguel Nogueira, Juan José Camarena, David Navarro, Eliseo Albert, Ignacio Torres, Maitane Aranzamendi Zaldumbide, Óscar Martínez Expósito, Nerea Antona Urieta, María de Toro, María Pilar Bea-Escudero, Jose Antonio Boga, Cristian Castelló-Abietar, Susana Rojo-Alba, Marta Elena Álvarez-Argüelles, Santiago Melón, Elisa Martró, Antoni E. Bordoy, Anna Not, Adrián Antuori, Anabel Fernández-Navarro, Andrés Canut-Blasco, Silvia Hernáez Crespo, Maria Luz Cordón Rodríguez, Maria Concepción Lecaroz Agara, Carmen Gómez-González, Amaia Aguirre-Quiñonero, José Israel López-Mirones, Marina Fernández-Torres, Maria Rosario Almela-Ferrer, Ana Carvajal, Juan Miguel Fregeneda-Grandes, Héctor Argüello, Gustavo Cilla Eguiluz, Milagrosa Montes Ros, Luis Piñeiro Vázquez, Ane Sorarrain, José María Marimón, José J. Costa-Alcalde, Rocío Trastoy, Gema Barbeito Castiñeiras, Amparo Coira, María Luisa Pérez del Molino, Antonio Aguilera, Begoña Palop-Borrás, Inmaculada de Toro Peinado, Maria Concepción Mediavilla Gradolph, Mercedes Pérez-Ruiz, Mirian Fernández-Alonso, Jose Luis del Pozo, Oscar González-Recio, Mónica Gutiérrez-Rivas, Jovita Fernández-Pinero, Miguel Ángel Jiménez Clavero, Begoña Fuster Escrivá, Concepción Gimeno Cardona, María Dolores Ocete Mochón, Rafael Medina-Gonzalez, José Antonio Lepe, Verónica González Galán, Ángel Rodríguez-Villodres, Nieves Gonzalo Jiménez, Jordi Reina, Carla López-Causapé, Maria Dolores Gómez-Ruiz, Eva M. Gonzalez-Barbera, José Luis López-Hontangas, Vicente Martín, Antonio J. Molina, Tania Fernandez-Villa, Ana Milagro Beamonte, Nieves Felisa Martínez-Cameo, Yolanda Gracia-Grataloup, Rosario Moreno-Muñoz, Maria Dolores Tirado Balaguer, José María Navarro-Marí, Irene Pedrosa-Corral, Sara Sanbonmatsu-Gámez, Antonio Oliver, Mónica Parra Grande, Bárbara Gómez Alonso, Francisco José Arjona Zaragozí, Maria Carmen Pérez González, Francisco Javier Chamizo López, Ana Bordes-Benítez, Núria Rabella, Ferran Navarro, Elisenda Miró, Antonio Rezusta, Alexander Tristancho, Encarnación Simarro Córdoba, Julia Lozano-Serra, Lorena Robles Fonseca, Álex Soriano, Francisco Javier Roig Sena, Hermelinda Vanaclocha Luna, Isabel Sanmartín, Daniel García-Souto, Ana Pequeño-Valtierra, Jose M. C. Tubio, Javier Temes, Jorge Rodríguez-Castro, Martín Santamarina García, Manuel Rodríguez-Iglesias, Fátima Galán-Sanchez, Salud Rodríguez-Pallares, José Manuel Azcona-Gutiérrez, Miriam Blasco-Alberdi, Alfredo Mayor, Alberto L. García-Basteiro, Gemma Moncunill, Carlota Dobaño, Pau Cisteró, Oriol Mitjà, Camila González-Beiras, Martí Vall-Mayans, Marc Corbacho-Monné, Andrea Alemany, Cristina Muñoz-Cuevas, Guadalupe Rodríguez-Rodríguez, Rafael Benito, Sonia Algarate, Jessica Bueno, Andrea Vergara-Gómez, Miguel J. Martínez, Jordi Vila, Elisa Rubio, Aida Peiró-Mestres, Jessica Navero-Castillejos, David Posada, Diana Valverde, Nuria Estévez, Iria Fernández-Silva, Loretta de Chiara, Pilar Gallego-García, Nair Varela, Ulises Gómez-Pinedo, Mónica Gozalo-Margüello, Maria Eliecer Cano García, José Manuel Méndez-Legaza, Jesus Rodríguez-Lozano, María Siller, Daniel Pablo-Marcos, Maria Montserrat Ruiz-García, Antonio Galiana, Judith Sánchez-Almendro, Maria Isabel Gascón Ros, Cristina Juana Torregrosa-Hetland, Eva María Pastor Boix, Paloma Cascales Ramos, Pedro Luis Garcinuño Enríquez, Salvador Raga Borja, Julia González Cantó, Olalla Martínez Macias, Adolfo de Salazar, Laura Viñuela González, Natalia Chueca, Federico García, Cristina Gómez-Camarasa, Amparo Farga Martí, Rocío Falcón, Victoria Domínguez-Márquez, Anna M. Planas, Israel Fernández-Cádenas, Maria Ángeles Marcos, Carmen Ezpeleta, Ana Navascués, Ana Miqueleiz Zapatero, Manuel Segovia, Antonio Moreno-Docón, Esther Viedma, Raúl Recio Martínez, Irene Muñoz-Gallego, Sara Gonzalez-Bodi, Maria Dolores Folgueira, Jesús Mingorance, Elias Dahdouh, Fernando Lázaro-Perona, María Rodríguez-Tejedor, María Pilar Romero-Gómez, Julio García-Rodríguez, Juan Carlos Galán, Mario Rodríguez-Dominguez, Laura Martínez-García, Melanie Abreu Di Berardino, Manuel Ponce-Alonso, Jose Maria González-Alba, Ivan Sanz-Muñoz, Diana Pérez San José, Maria Gil Fortuño, Juan B. Bellido-Blasco, Alberto Yagüe Muñoz, Noelia Hernández Pérez, Helena Buj Jordá, Óscar Pérez Olaso, Alejandro González Praetorius, Nora Mariela Martínez Ramírez, Aida Ramírez Marinero, Eduardo Padilla León, Alba Vilas Basil, Mireia Canal Aranda, Albert Bernet Sánchez, Alba Bellés Bellés, Eric López González, Iván Prats Sánchez, Mercè García-González, Miguel José Martínez-Lirola, Manuel Ángel Rodríguez Maresca, Maria Teresa Cabezas Fernández, María Eugenia Carrillo Gil, Maria Paz Ventero Martín, Carmen Molina Pardines, Nieves Orta Mira, María Navarro Cots, Inmaculada Vidal Catalá, Isabel García Nava, Soledad Illescas Fernández-Bermejo, José Martínez-Alarcón, Marta Torres-Narbona, Cristina Colmenarejo, Lidia García-Agudo, Jorge A. Pérez García, Martín Yago López, María Ángeles Goberna Bravo, Victoria Simón García, Gonzalo Llop Furquet, Agustín Iranzo Tatay, Sandra Moreno-Marro, Noelia Lozano Rodríguez, Amparo Broseta Tamarit, Juan José Badiola Díez, Amparo Martínez-Ramírez, Ana Dopazo, Sergio Callejas, Alberto Benguría, Begoña Aguado, Antonio Alcamí, Marta Bermejo Bermejo, Ricardo Ramos-Ruíz, Víctor Manuel Fernández Soria, Fernando Simón Soria & Mercedes Roig Cardells, The coronavirus disease 2019 (COVID-19) pandemic has affected the world radically since 2020. Spain was one of the European countries with the highest incidence during the first wave. As a part of a consortium to monitor and study the evolution of the epidemic, we sequenced 2,170 samples, diagnosed mostly before lockdown measures. Here, we identified at least 500 introductions from multiple international sources and documented the early rise of two dominant Spanish epidemic clades (SECs), probably amplified by superspreading events. Both SECs were related closely to the initial Asian variants of SARS-CoV-2 and spread widely across Spain. We inferred a substantial reduction in the effective reproductive number of both SECs due to public-health interventions (Re, This work was mainly funded by the Instituto de Salud Carlos III project COV20/00140, with additional funding by Spanish National Research Council project CSIC-COV19-021, Ministerio de Ciencia project PID2019-104477RB-100, ERC StG 638553 and ERC CoG 101001038 to I.C., and BFU2017-89594R to F.G.C. M.C. is supported by Ramón y Cajal program from Ministerio de Ciencia and grants RTI2018-094399-A-I00 and Generalitat Valenciana (Regional Government) project SEJI/2019/011. We gratefully acknowledge Hospital Universitari Vall d’Hebron, Instituto de Salud Carlos III, IrsiCaixa AIDS Research Lab and all the international researchers and institutions that submitted sequenced SARS-CoV-2 genomes to the GISAID’s EpiCov Database (Supplementary Table 1), as an important part of our analyses has been made possible by the sharing of their work. We also thank Unidad de Bioinformática y Estadística, Centro de Investigación Príncipe Felipe, for allowing us to use the Computer Cluster to perform some of the bioinformatic analysis.
- Published
- 2021
45. Determination of the concentration of igg against the spike receptor-binding domain that predicts the viral neutralizing activity of convalescent plasma and serum against sars-cov-2
- Author
-
Santiago, Llipsy, Uranga-Murillo, Iratxe, Arias, Maykel, González-Ramírez, Andrés Manuel, Macías-León, Javier, Moreo, Eduardo, Redrado, Sergio, García-García, Ana, Taleb, Víctor, Lira-Navarrete, Erandi, Hurtado-Guerrero, Ramón, Aguilo, Nacho, Encabo-Berzosa, Maria Del Mar, Hidalgo, Sandra, Galvez, Eva M., Ramirez-Labrada, Ariel, de Miguel, Diego, Benito, Rafael, Miranda, Patricia, Fernández, Antonio, Domingo, José María, Serrano, Laura, Yuste, Cristina, Villanueva-Saz, Sergio, Paño-Pardo, José Ramón, Pardo, Julián, Santiago, Llipsy, Uranga-Murillo, Iratxe, Arias, Maykel, González-Ramírez, Andrés Manuel, Macías-León, Javier, Moreo, Eduardo, Redrado, Sergio, García-García, Ana, Taleb, Víctor, Lira-Navarrete, Erandi, Hurtado-Guerrero, Ramón, Aguilo, Nacho, Encabo-Berzosa, Maria Del Mar, Hidalgo, Sandra, Galvez, Eva M., Ramirez-Labrada, Ariel, de Miguel, Diego, Benito, Rafael, Miranda, Patricia, Fernández, Antonio, Domingo, José María, Serrano, Laura, Yuste, Cristina, Villanueva-Saz, Sergio, Paño-Pardo, José Ramón, and Pardo, Julián
- Abstract
Several hundred millions of people have been diagnosed of coronavirus disease 2019 (COVID-19), causing millions of deaths and a high socioeconomic burden. SARS-CoV-2, the causative agent of COVID-19, induces both specific T-and B-cell responses, being antibodies against the virus detected a few days after infection. Passive immunization with hyperimmune plasma from convalescent patients has been proposed as a potentially useful treatment for COVID-19. Using an in-house quantitative ELISA test, we found that plasma from 177 convalescent donors contained IgG antibodies specific to the spike receptor-binding domain (RBD) of SARS-CoV-2, although at very different concentrations which correlated with previous disease severity and gender. Anti-RBD IgG plasma concentrations significantly correlated with the plasma viral neutralizing activity (VN) against SARS-CoV-2 in vitro. Similar results were found using an independent cohort of serum from 168 convalescent health workers. These results validate an in-house RBD IgG ELISA test in a large cohort of COVID-19 convalescent patients and indicate that plasma from all convalescent donors does not contain a high enough amount of anti-SARS-CoV-2-RBD neutralizing IgG to prevent SARS-CoV-2 infection in vitro. The use of quantitative anti-RBD IgG detection systems might help to predict the efficacy of the passive immunization using plasma from patients recovered from SARS-CoV-2.
- Published
- 2021
46. SARS‐CoV‐2 congenital infection and pre‐eclampsia‐like syndrome in dichorionic twins: A case report and review of the literature
- Author
-
Abadía‐Cuchí, Natalia, primary, Ruiz‐Martínez, Sara, additional, Fabre, Marta, additional, Mateo, Purificación, additional, Remacha Sienes, María, additional, Ventura Faci, Purificación, additional, Bueno Sancho, Jessica, additional, Benito, Rafael, additional, and Paules, Cristina, additional
- Published
- 2021
- Full Text
- View/download PDF
47. Discrepancy results with meningitis/encephalitis panel FILMARRAY in cerebrospinal fluid
- Author
-
Ochoa, Cristina Matovelle, Pareja, Juan Sahagún, Algarate, Sonia, Gil, Joaquina, Ushakova, Tatiana Khaliulina, Gonzalo, Soledad Salvo, and Benito, Rafael
- Published
- 2020
- Full Text
- View/download PDF
48. Determination of the Concentration of IgG against the Spike Receptor-Binding Domain That Predicts the Viral Neutralizing Activity of Convalescent Plasma and Serum against SARS-CoV-2
- Author
-
Santiago, Llipsy, primary, Uranga-Murillo, Iratxe, additional, Arias, Maykel, additional, González-Ramírez, Andrés Manuel, additional, Macías-León, Javier, additional, Moreo, Eduardo, additional, Redrado, Sergio, additional, García-García, Ana, additional, Taleb, Víctor, additional, Lira-Navarrete, Erandi, additional, Hurtado-Guerrero, Ramón, additional, Aguilo, Nacho, additional, del Mar Encabo-Berzosa, Maria, additional, Hidalgo, Sandra, additional, Galvez, Eva M., additional, Ramirez-Labrada, Ariel, additional, de Miguel, Diego, additional, Benito, Rafael, additional, Miranda, Patricia, additional, Fernández, Antonio, additional, Domingo, José María, additional, Serrano, Laura, additional, Yuste, Cristina, additional, Villanueva-Saz, Sergio, additional, Paño-Pardo, José Ramón, additional, and Pardo, Julián, additional
- Published
- 2021
- Full Text
- View/download PDF
49. Bleeding Duodenal Ulcer and Association with Polymorphism of Endothelial Constitutive Nitric Oxide Synthase Gene
- Author
-
Serrano, Trinidad, Piazuelo, Elena, Benito, Rafael, Santolaria, Santos, and Lanas, Angel
- Published
- 2002
- Full Text
- View/download PDF
50. Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype
- Author
-
García-González, M Asunción, Quintero, Enrique, Bujanda, Luis, Nicolás, David, Benito, Rafael, Strunk, Mark, Santolaria, Santos, Sopeña, Federico, Badía, María, Hijona, Elizabeth, Pérez-Aísa, M Angeles, Méndez-Sánchez, Isabel M, Thomson, Concha, Carrera, Patricia, Piazuelo, Elena, Jiménez, Pilar, Espinel, Jesús, Campo, Rafael, Manzano, Marisa, Geijo, Fernando, Pellisé, Maria, González-Huix, Ferrán, Espinós, Jorge, Titó, LLusia, Zaballa, Manuel, Pazo, Roberto, and Lanas, Angel
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.